Here's Why You Should Retain CONMED Stock in Your Portfolio Now
CNMD is sharpening its focus on AirSeal, Buffalo Filter and BioBrace, betting on higher-growth platforms to drive margin gains and long-term growth.
Is the Options Market Predicting a Spike in CONMED Stock?
Investors need to pay close attention to CNMD stock based on the movements in the options market lately.
CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript
CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates
Conmed (CNMD) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.95 per share a year ago.
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
CNMD's high-margin platforms, supply-chain recovery and margin expansion plans support growth, though tariffs and portfolio shifts weigh on near-term results.
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
CNMD's growth rests on AirSeal, Buffalo Filter and BioBrace as supply chains normalize, even as tariffs and a GI exit pressure EPS.
Conmed (CNMD) Up 22.9% Since Last Earnings Report: Can It Continue?
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
CNMD's growth rests on AirSeal, Buffalo Filter and BioBrace as supply chains normalize, even as tariffs and a GI exit pressure EPS.
CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up
CNMD posts strong fourth-quarter 2025 results with EPS and revenue beat, driven by surgical growth and improved gross margin.
Compared to Estimates, Conmed (CNMD) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Conmed (CNMD) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CONMED Corporation (CNMD) Q4 2025 Earnings Call Transcript
CONMED Corporation (CNMD) Q4 2025 Earnings Call Transcript
